Name
Dexrazoxane
Alternate Names
ADR-529
ICRF-187
Zinecard
Abbreviations
None
Category
Ancillary Agent
Subcategory
Cardioprotectant
NSC Number
169780
Primary Site
None
Histology
None
Remarks
A cardioprotective agent, may have synergistic activity when given with other antineoplastic drugs. FDA approved for reducing cardiomyopathy related doxorubicin. Little if any antitumor effect in multiple studies of various cancers.
Coding
This drug should NOT be coded